The global osteoarthritis drug market size is expected to generate around USD 10,327 million by 2025, at a CAGR of around 8.1% between 2019 and 2025. The primary factor likely to drive the global osteoarthritis drug market over the estimated timeframe is the constantly rising aging population.
Osteoarthritis Drug Market
The report covers a forecast and an analysis of the osteoarthritis drug market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the osteoarthritis drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the osteoarthritis drug market on a global level.
In order to give the users of this report a comprehensive view of the osteoarthritis drug market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the osteoarthritis drug market by segmenting the market based on drug class, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2019 to 2025.
Based on drug class, the osteoarthritis drug market is segmented as NSAIDs, corticosteroids, viscosupplementation agents, and others. By route of administration, the osteoarthritis drug market is segmented into topical, parenteral, and oral. Based on distribution channel, the osteoarthritis drug market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further division into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some major players of the global osteoarthritis drug market include Pfizer Inc., Horizon Pharma plc, Ferring B.V., Bioventus, Inc., Sanofi, Flexion Therapeutics, Inc., Alkem Laboratories, Anika Therapeutics, Inc., Chugai Pharmaceutical Co., Limited, and Zimmer Biomet Holdings, Inc., among others.
This report segments the global osteoarthritis drug market into:
Global Osteoarthritis Drug Market: Drug Class Analysis
Global Osteoarthritis Drug Market: Route of Administration Analysis
Global Osteoarthritis Drug Market: Distribution Channel Analysis
Global Osteoarthritis Drug Market: Regional Analysis
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed